{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:54:25Z","timestamp":1794862465420,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015899","name":"Banff International Research Station","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.128780","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:25:25Z","timestamp":1789971925000},"page":"128780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The case for model-informed vaccine development"],"prefix":"10.1016","volume":"92","author":[{"given":"Jane P.F.","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Beigmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Desikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Easlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gazeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kirpichnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranesh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Skibinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2026.128780_bb0005","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s11095-022-03288-w","article-title":"Review: role of model-informed drug development approaches in the lifecycle of drug development and regulatory decision-making","volume":"39","author":"Madabushi","year":"2022","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128780_bb0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/cpt.3006","article-title":"Model-informed drug development: steps toward harmonized guidance","volume":"114","author":"Marshall","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128780_bb0015","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/psp4.12709","article-title":"Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration","volume":"10","author":"Bai","year":"2021","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128780_bb0020","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/psp4.13208","article-title":"Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update report","volume":"13","author":"Bai","year":"2024","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128780_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cpt.3636","article-title":"Impact of model-informed drug development on drug development cycle times and clinical trial cost","volume":"118","author":"Sahasrabudhe","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2026.128780_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116823","article-title":"A comprehensive review on pharmacokinetic studies of vaccines: impact of delivery route, carrier-and its modulation on immune response","volume":"236","author":"Jha","year":"2023","journal-title":"Environ Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.xphs.2023.10.043","article-title":"A quantitative clinical pharmacology-based framework for model-informed vaccine development","volume":"113","author":"Desikan","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2026.128780_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41541-018-0075-3","article-title":"Using vaccine immunostimulation\/immunodynamic modelling methods to inform vaccine dose decision-making","volume":"3","author":"Rhodes","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.128780_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1596518","article-title":"A consensus mathematical model of vaccine-induced antibody dynamics for multiple vaccine platforms and pathogens","volume":"16","author":"Wilding","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128780_bb0050","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75427","article-title":"Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection","volume":"11","author":"Alexandre","year":"2022","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128780_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005692","article-title":"Multi-epitope models explain how pre-existing antibodies affect the generation of broadly protective responses to influenza","volume":"12","author":"Zarnitsyna","year":"2016","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128780_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006505","article-title":"Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design","volume":"14","author":"Handel","year":"2018","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128780_bb0065","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.celrep.2019.11.030","article-title":"Preferential presentation of high-affinity immune complexes in germinal centers can explain how passive immunization improves the humoral response","volume":"29","author":"Garg","year":"2019","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128780_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70356","article-title":"Bench to bedside modeling of mRNA encoding IgG using a multiscale mechanistic pharmacokinetic-toxicokinetic (PK-TK) model: a case study with anti-claudin 18.2","volume":"18","author":"Desai","year":"2025","journal-title":"Clin Transl Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128780_bb0075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2015.01.027","article-title":"Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.vaccine.2026.128780_bb0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1614940113","article-title":"Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens","volume":"113","author":"Shaffer","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"43","key":"10.1016\/j.vaccine.2026.128780_bb0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128780_bb0090","doi-asserted-by":"crossref","first-page":"20077","DOI":"10.1073\/pnas.1919329117","article-title":"Optimizing immunization protocols to elicit broadly neutralizing antibodies","volume":"117","author":"Sprenger","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128780_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1013163","article-title":"Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions","volume":"21","author":"Voutouri","year":"2025","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-018-0252-1","article-title":"A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine","volume":"19","author":"Bonin","year":"2018","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2026.128780_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104264","article-title":"Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach","volume":"84","author":"Kandala","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.128780_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103651","article-title":"Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis","volume":"73","author":"Maas","year":"2021","journal-title":"EBioMedicine"},{"issue":"21","key":"10.1016\/j.vaccine.2026.128780_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.07.049","article-title":"Modeling antigen-specific T cell dynamics following Hepatitis B vaccination indicates differences between conventional and regulatory T cell dynamics","volume":"42","author":"Besbassi","year":"2024","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128780_bb0120","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/psp4.12700","article-title":"Application of quantitative systems pharmacology to guide the optimal dosing of COVID-19 vaccines","volume":"10","author":"Giorgi","year":"2021","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128780_bb0125","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/psp4.70041","article-title":"A multiscale quantitative systems pharmacology model for the development and optimization of mRNA vaccines","volume":"14","author":"Dasti","year":"2025","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128780_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/psp4.70188","article-title":"Immunostimulatory and immunodynamic modeling analysis to determine a plausible starting dose of mRNA-4359 for use in first-in-human trials","volume":"15","author":"Greene","year":"2026","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128780_bb0135","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1016\/j.vaccine.2022.10.012","article-title":"Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation\/immunodynamic modelling","volume":"40","author":"Rhodes","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41541-021-00377-6","article-title":"A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data","volume":"6","author":"Dudasova","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12874-024-02197-3","article-title":"Elucidating vaccine efficacy using a correlate of protection, demographics, and logistic regression","volume":"24","author":"Dudasova","year":"2024","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41541-024-00937-6","article-title":"Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models","volume":"9","author":"Dudasova","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/psp4.13237","article-title":"Immunostimulatory\/immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection","volume":"14","author":"Ivaturi","year":"2025","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128780_bb0160","article-title":"Heterogeneity in vaccinal immunity to SARS-CoV-2 can be addressed by a personalized booster strategy","volume":"11","author":"Stoddard","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s43856-025-00807-9","article-title":"Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease","volume":"5","author":"Plock","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.vaccine.2026.128780_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.776933","article-title":"Increased B cell selection stringency in germinal centers can explain improved COVID-19 vaccine efficacies with low dose prime or delayed boost","volume":"12","author":"Garg","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128780_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s43588-022-00198-0","article-title":"Modeling how antibody responses may determine the efficacy of COVID-19 vaccines","volume":"2","author":"Padmanabhan","year":"2022","journal-title":"Nat Comput Sci"},{"key":"10.1016\/j.vaccine.2026.128780_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2014.00177","article-title":"Mathematical modeling provides kinetic details of the human immune response to vaccination","volume":"4","author":"Le","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"issue":"18","key":"10.1016\/j.vaccine.2026.128780_bb0185","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.vaccine.2007.01.012","article-title":"Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules","volume":"25","author":"Wilson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128780_bb0190","series-title":"Quantifying the waning of humoral immunity","author":"Saha","year":"2025"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128780_bb0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/abt\/tbab013","article-title":"Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection","volume":"4","author":"Bottino","year":"2021","journal-title":"Antibody Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-023-00271-y","article-title":"Understanding repertoire sequencing data through a multiscale computational model of the germinal center","volume":"9","author":"Garc\u00eda-Valiente","year":"2023","journal-title":"npj Syst Biol Appl"},{"key":"10.1016\/j.vaccine.2026.128780_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.985478","article-title":"Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity","volume":"13","author":"Desikan","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128780_bb0210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/vaccines13040368","article-title":"The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis","volume":"13","author":"Yuan","year":"2025","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128780_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000497","article-title":"Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population","volume":"3","author":"Nakamura","year":"2024","journal-title":"PLOS Digit Health"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128780_bb0220","doi-asserted-by":"crossref","first-page":"e1009753","DOI":"10.1371\/journal.ppat.1009753","article-title":"COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes","volume":"17","author":"Jenner","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128780_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fsysb.2023.1174647","article-title":"A practical guide for the generation of model-based virtual clinical trials","volume":"3","author":"Craig","year":"2023","journal-title":"Front Syst Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128780_bb0230","article-title":"Stochastic modeling of a gene regulatory network driving B cell development in germinal centers","volume":"19","author":"Al-Rashedi","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128780_bb0235","series-title":"Pharmacometrics: a shot in the arm for vaccine discovery and development \u223cor\u223c vaccines are not immune to the charms of pharmacometrics","author":"Sachs","year":"2019"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128780_bb0245","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(21)00627-7","article-title":"Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study","volume":"22","author":"Birger","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0250","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2026.2649059","article-title":"Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65\u201384years of age in Belgium: an epidemiological modeling study","volume":"22","author":"Vandenplas","year":"2026","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128780_bb0260","doi-asserted-by":"crossref","DOI":"10.1098\/rsbl.2017.0660","article-title":"Mechanistic models versus machine learning, a fight worth fighting for the biological community?","volume":"14","author":"Baker","year":"2018","journal-title":"Biol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128780_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s10928-025-09984-5","article-title":"The dawn of a new era: can machine learning and large language models reshape QSP modeling?","volume":"52","author":"Androulakis","year":"2025","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70124","article-title":"Integrating model-informed drug development with AI: a synergistic approach to accelerating pharmaceutical innovation","volume":"18","author":"Raman","year":"2025","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0275","article-title":"Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges","volume":"16","author":"Ye","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128780_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00751","article-title":"The development of a vaccine against meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front Immunol"},{"issue":"7662","key":"10.1016\/j.vaccine.2026.128780_bb0285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"7662","key":"10.1016\/j.vaccine.2026.128780_bb0290","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128780_bb0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41590-024-02036-z","article-title":"System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans","volume":"26","author":"Cortese","year":"2025","journal-title":"Nat Immunol"},{"issue":"7978","key":"10.1016\/j.vaccine.2026.128780_bb0300","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized mRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2026.129245","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000}},{"DOI":"10.1016\/j.vaccine.2026.129245","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,20]],"date-time":"2026-12-20T00:00:00Z","timestamp":1797724800000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600589X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600589X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:40:31Z","timestamp":1793605231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600589X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"alternative-id":["S0264410X2600589X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128780","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case for model-informed vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128780"}}